Loading...
A randomized controlled trial of probiotics for Clostridium difficile infection in adults (PICO)
BACKGROUND: Clostridium difficile is the most common cause of hospital-acquired infections, responsible for >450000 infections annually in the USA. Probiotics provide a promising, well-tolerated adjunct therapy to standard C. difficile infection (CDI) treatment regimens, but there is a paucity of...
Saved in:
| Published in: | J Antimicrob Chemother |
|---|---|
| Main Authors: | , , , , , , |
| Format: | Artigo |
| Language: | Inglês |
| Published: |
Oxford University Press
2017
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5890711/ https://ncbi.nlm.nih.gov/pubmed/28961980 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/jac/dkx254 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|